Globe Gazette Mason City
The Drug Company That Prospered Without Creating Any Drugs
North Central Iowa
•
Apr 13, 2023
Amgen
Latest Iowa stories tagged “Amgen”.
Globe Gazette Mason City
Quad Cities Times | Davenport
The Drug Company That Prospered Without Creating Any Drugs
Eastern Iowa
•
Apr 13, 2023
Globe Gazette Mason City
Amgen to buy Horizon Therapeutics in $26.4B deal
North Central Iowa
•
Dec 12, 2022
Siouxland Business Journal
Amgen to buy Horizon Therapeutics in $26.4B deal
Iowa Business
•
Dec 12, 2022
Quad Cities Times | Davenport
Amgen to buy Horizon Therapeutics in $26.4B deal
Eastern Iowa
•
Dec 12, 2022
Denison Bulletin & Review
Amgen to buy Horizon Therapeutics in $26.4B deal
Western Iowa
•
Dec 12, 2022
Oelwein Daily Register
Boehringer Ingelheim Enters Clinical Collaboration with Amgen to Study BI 1701963, a SOS1::pan-KRAS Inhibitor, in Combination with LUMAKRAS (sotorasib), a KRASG12C...
Northeast Iowa
•
Sep 16, 2021
Oelwein Daily Register
Labcorp Launches Companion Diagnostic for Amgen's Newly-approved Lung Cancer Therapy
Northeast Iowa
•
Jul 1, 2021
Oelwein Daily Register
Guardant360 CDx Receives FDA Approval as First and Only Liquid Biopsy Companion Diagnostic for Amgen's LUMAKRAS (sotorasib) KRASG12C Inhibitor for Use in Advanced...
Northeast Iowa
•
May 28, 2021
Oelwein Daily Register
Amgen and McKesson Launch Strategic Agreement to Advance Cancer Innovation in Communities
Northeast Iowa
•
Dec 4, 2020
Oelwein Daily Register
Global Coalition for Adaptive Research, Amgen, and Eisai Announce First Patient Enrolled in International COVID-19 Trial
Northeast Iowa
•
Oct 26, 2020
Oelwein Daily Register
Analysis on Impact of COVID-19- Global Hepatocellular Carcinoma Drugs Market 2020-2024 | Evolving Opportunities with AbbVie Inc. and Amgen Inc. | Technavio
Northeast Iowa
•
Aug 10, 2020
Keokuk Daily Gate City
Analysis on Impact of COVID-19- Global Hepatocellular Carcinoma Drugs Market 2020-2024 | Evolving Opportunities with AbbVie Inc. and Amgen Inc. | Technavio
Southeast Iowa
•
Aug 10, 2020
Fort Madison Daily Democrat
Analysis on Impact of Covid-19 - Global Anti-inflammatory Therapeutics Market 2020-2024 | Evolving Opportunities with AbbVie Inc. and Amgen Inc. | Technavio
Southeast Iowa
•
Apr 3, 2020
Oelwein Daily Register
Analysis on Impact of Covid-19 - Global Anti-inflammatory Therapeutics Market 2020-2024 | Evolving Opportunities with AbbVie Inc. and Amgen Inc. | Technavio
Northeast Iowa
•
Apr 3, 2020
Keokuk Daily Gate City
Global Cervical Cancer Therapeutics Market 2020-2024 | Evolving Opportunities with Amgen Inc. and Biocon Ltd. | Technavio
Southeast Iowa
•
Mar 12, 2020
Oelwein Daily Register
Global Regenerative Medicine Market 2020-2024 | Evolving Opportunities with Allergan Plc and Amgen Inc. | Technavio
Northeast Iowa
•
Feb 18, 2020
Fort Madison Daily Democrat
BioMed Realty Welcomes Amgen to Its Gateway of Pacific Campus
Southeast Iowa
•
Dec 9, 2019
Fort Madison Daily Democrat
Amgen Gift to Fund Launch of KGI Center for Training in Applied Genomics
Southeast Iowa
•
Dec 5, 2019
Oelwein Daily Register
Amgen Gift to Fund Launch of KGI Center for Training in Applied Genomics
Northeast Iowa
•
Dec 5, 2019
Oelwein Daily Register
Global Wearable Injectors Market 2020-2024 | Evolving Opportunities with Amgen Inc. & Becton, Dickinson and Co. | Technavio
Northeast Iowa
•
Nov 18, 2019
Oelwein Daily Register
Bristol-Myers Squibb Announces Agreement Between Celgene and Amgen to Divest OTEZLA for $13.4 Billion
Northeast Iowa
•
Aug 26, 2019
Keokuk Daily Gate City
Bristol-Myers Squibb Announces Agreement Between Celgene and Amgen to Divest OTEZLA for $13.4 Billion
Southeast Iowa
•
Aug 26, 2019
Fort Madison Daily Democrat
Amgen Tour of California Competitors Announced
Southeast Iowa
•
May 10, 2019